Vimarsana
Biggest News Aggregation in the World

Page 8 - Buzz Show News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Buzz Show. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Buzz Show Today - Breaking & Trending Today

"The Buzz" Show: Isoray Inc. (NYSE: ISR) Surges Upon FDA Clearance of its Sirius® Positive-Signal - Vimarsana News

"The Buzz" Show: Isoray Inc. (NYSE: ISR) Surges Upon FDA Clearance of its Sirius® Positive-Signal

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Isoray Inc. Surges Upon FDA Clearance  of its Sirius® Positive-Signal” Isoray Inc. (NYSE: ISR) shot up over 227% in premarket trading after C4 Imaging announced its receipt of an FDA clearance. C4 Imaging announced FDA clearance for the use of its Sirius® positive-signal MRI Markers with Isoray’s Cesium-131, brachytherapy seeds. Isoray, Inc., through its subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the bod...

"The Buzz" Show: Professional Diversity Network (NASDAQ: IPDN) Partnership with Phala Network - Vimarsana News

"The Buzz" Show: Professional Diversity Network (NASDAQ: IPDN) Partnership with Phala Network

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on ““The Buzz” Show: Professional Diversity Network (NASDAQ: IPDN) Surges Amid Partnership with Phala Network”

"The Buzz" Show: Arcturus Therapeutics (NASDAQ: ARCT) Shares Fall After Analyst Downgrade Stock - Vimarsana News

"The Buzz" Show: Arcturus Therapeutics (NASDAQ: ARCT) Shares Fall After Analyst Downgrade Stock

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Arcturus Therapeutics Shares Fall After Analyst Downgrade Stock” Arcturus Therapeutics (NASDAQ: ARCT) plunged over 41% after analysts downgraded the company on disappointing results from a Phase 1/2 trial of its COVID-19 vaccine candidate. Even though the company had been granted approval from the Singapore Health Sciences Authority to move ahead with a Phase 2 study, analysts were worried that the candidate would not be able to achieve competitive levels of vaccine efficacy with single-shot dosing. Found...

"The Buzz" Show: Ideanomics (NASDAQ: IDEX) Surges Following Agreement with Meihao Chuxing - Vimarsana News

"The Buzz" Show: Ideanomics (NASDAQ: IDEX) Surges Following Agreement with Meihao Chuxing

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on ““The Buzz” Show: Ideanomics Surges Following Agreement with Meihao Chuxing” Ideanomics (NASDAQ: IDEX) shot up over 13% in premarket trading after announcing an agreement with Meihao Chuxing. The Company will now buy an initial 2,000 electric ride-hailing vehicles from the joint venture between China’s BYD and Didi and Ideanomics expects deliveries to begin in the first half of next year. Ideanomics is a global company focused on the convergence of financial services and industries experiencing techno...

"The Buzz" Show: Greenpro Capital (NASDAQ: GRNQ) Prepares to Set Up Bitcoin Fund for Investment - Vimarsana News

"The Buzz" Show: Greenpro Capital (NASDAQ: GRNQ) Prepares to Set Up Bitcoin Fund for Investment

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on ““The Buzz” Show: Greenpro Capital Prepares to Set Up Bitcoin Fund for Investment” Greenpro Capital (NASDAQ: GRNQ) surged over 86% in premarket trading after announcing that it intends to set up a Bitcoin Fund for investment. The Company expects to use its subsidiary, CryptoSX to acquire its BTC stake and believes that the cryptocurrency is a reliable future store of value. Headquartered in Kuala Lumpur, Greenpro Capital Corp., a Nevada corporation, with strategic offices across Asia, is a business incu...